mhurhangee/ep-ind-claims huggingface dataset:
An attenuation map generation method, comprising: receiving computed tomography "CT" image data of a subject detected by an X-ray detector; and generating an attenuation map for Positron Emission Tomography "PET" image reconstruction by inputting the received CT image data into a trained deep convolutional neural network "DCNN" model that outputs the attenuation map, characterised in that the received CT image data are integration CT image data, and in that the DCNN model was trained using phantom or patient scan data and/ or data from a digital phantom simulation to generate initial single-energy CT images and, in combination with high-dose spectral images, to generate corresponding training attenuation map data generated from the spectral CT image data. receiving computed tomography "CT" image data of a subject detected by an X-ray detector; and generating an attenuation map for Positron Emission Tomography "PET" image reconstruction by inputting the received CT image data into a trained deep convolutional neural network "DCNN" model that outputs the attenuation map, characterised in that the received CT image data are integration CT image data, and in that the DCNN model was trained using phantom or patient scan data and/ or data from a digital phantom simulation to generate initial single-energy CT images and, in combination with high-dose spectral images, to generate corresponding training attenuation map data generated from the spectral CT image data.
A power cable comprising a conductor surrounded by at least an insulation layer and a jacketing layer, wherein at least said jacketing layer comprises: a polymer composition obtained in the presence of a single site catalyst comprising a multimodal copolymer of ethylene with one or more comonomers, wherein the multimodal ethylene copolymer consists of a lower weight average molecular weight component and a higher molecular weight average molecular weight component, has a density of from 940 to 977 kg/m 3, and a Constant Tensile Load at 5 MPa of at least 30 hours; and carbon black. a polymer composition obtained in the presence of a single site catalyst comprising a multimodal copolymer of ethylene with one or more comonomers, wherein the multimodal ethylene copolymer consists of a lower weight average molecular weight component and a higher molecular weight average molecular weight component, has a density of from 940 to 977 kg/m 3, and a Constant Tensile Load at 5 MPa of at least 30 hours; and carbon black.
A toy character assembly, comprising: a housing; a toy character inside the housing; and a breakout element that is operable to break the housing to expose the toy character, wherein the housing includes a plurality of fracture elements provided on an inside face thereof to facilitate fracture upon impact from the breakout element, wherein the fracture elements include a plurality of channels, characterised in that the plurality of channels are provided on the inside face of the housing. a housing; a toy character inside the housing; and a breakout element that is operable to break the housing to expose the toy character, wherein the housing includes a plurality of fracture elements provided on an inside face thereof to facilitate fracture upon impact from the breakout element, wherein the fracture elements include a plurality of channels, characterised in that the plurality of channels are provided on the inside face of the housing.
A method of diagnosing or monitoring non-alcoholic fatty liver disease (NAFLD) in a subject, comprising: determining an amount of one or more lipid metabolites in one or more plasma samples from the subject wherein: the lipid metabolites PC18:3n6, PC20:3n6, CE18:3n6, PC20:4n3, PC18:0, PC22:5n3, CE20:3n6, TG20:3n6, TG22:5n3, LYLC, LY18:0, LY20:3n6, FA18:1n9, FA20:3n6, and/or 15-HETE are positively associated with NAFLD; and the lipid metabolites TG22:2n6, PC18:2n6, PC20:2n6, SM16:0, PCLC, PC18:1n7, LY18:1n7, LY18:2n6, PGA2M, 6-keto-PGF1α, 11-DTXB2, 12,13-DiHOME, 9,10-EpOME, 12,13-EpOME and/or 19,20-DiHDPA are negatively associated with NAFLD; and correlating the amount(s) of the one or more lipid metabolites with the presence of NAFLD. determining an amount of one or more lipid metabolites in one or more plasma samples from the subject wherein: the lipid metabolites PC18:3n6, PC20:3n6, CE18:3n6, PC20:4n3, PC18:0, PC22:5n3, CE20:3n6, TG20:3n6, TG22:5n3, LYLC, LY18:0, LY20:3n6, FA18:1n9, FA20:3n6, and/or 15-HETE are positively associated with NAFLD; and the lipid metabolites TG22:2n6, PC18:2n6, PC20:2n6, SM16:0, PCLC, PC18:1n7, LY18:1n7, LY18:2n6, PGA2M, 6-keto-PGF1α, 11-DTXB2, 12,13-DiHOME, 9,10-EpOME, 12,13-EpOME and/or 19,20-DiHDPA are negatively associated with NAFLD; and the lipid metabolites PC18:3n6, PC20:3n6, CE18:3n6, PC20:4n3, PC18:0, PC22:5n3, CE20:3n6, TG20:3n6, TG22:5n3, LYLC, LY18:0, LY20:3n6, FA18:1n9, FA20:3n6, and/or 15-HETE are positively associated with NAFLD; and the lipid metabolites TG22:2n6, PC18:2n6, PC20:2n6, SM16:0, PCLC, PC18:1n7, LY18:1n7, LY18:2n6, PGA2M, 6-keto-PGF1α, 11-DTXB2, 12,13-DiHOME, 9,10-EpOME, 12,13-EpOME and/or 19,20-DiHDPA are negatively associated with NAFLD; and correlating the amount(s) of the one or more lipid metabolites with the presence of NAFLD.
A covered electrode comprising, based on the total mass of the covered electrode: 5% to 10% by mass metal carbonate on a CO 2 basis, 0.4% to 2.0% by mass alkali metal oxide on an alkali metal basis, and 1.0% to 5.0% by mass fluorine compound on a F basis in a covering of the covered electrode; and C: 0.04% to 0.15% by mass, S i: 1.0% to 1.5% by mass, Mn: 0.7% to 1.2% by mass, Cr: 1.3% to 1.9% by mass, Mo: 0.5% to 1.0% by mass, V: 0.3% to 0.5% by mass, Nb: 0.02% to 0.06% by mass, B: 0.005% to 0.015% by mass, Mg: 0.05% to 0.15% by mass, and Fe: 60% to 75% by mass in one of a core wire and the covering of the covered electrode or in both of the core wire and the covering in total; and incidental impurities, the incidental impurities being 0.10% or less by mass Cu, Ni, Ti, Al, Ta, Co, and W in total and 0.10% or less by mass S, Sn, As, Sb, Pb, and Bi in total. 5% to 10% by mass metal carbonate on a CO 2 basis, 0.4% to 2.0% by mass alkali metal oxide on an alkali metal basis, and 1.0% to 5.0% by mass fluorine compound on a F basis in a covering of the covered electrode; and C: 0.04% to 0.15% by mass, S i: 1.0% to 1.5% by mass, Mn: 0.7% to 1.2% by mass, Cr: 1.3% to 1.9% by mass, Mo: 0.5% to 1.0% by mass, V: 0.3% to 0.5% by mass, Nb: 0.02% to 0.06% by mass, B: 0.005% to 0.015% by mass, Mg: 0.05% to 0.15% by mass, and Fe: 60% to 75% by mass in one of a core wire and the covering of the covered electrode or in both of the core wire and the covering in total; and incidental impurities, the incidental impurities being 0.10% or less by mass Cu, Ni, Ti, Al, Ta, Co, and W in total and 0.10% or less by mass S, Sn, As, Sb, Pb, and Bi in total.
A method of operating an alert device of a vehicle (12; 112), the method comprising: I) capturing, by a camera (14, 114), an image (16, 116) including a lane marking (18, 118) on the left-side and on the right-side of the travel lane of a roadway (20, 120) of the host vehicle, and an object (22, 122) proximate to the vehicle (12, 112); II) determining, with a controller (32, 132) in communication with the camera (14, 114), a vehicle offset (36, 136) between the vehicle (12, 112) and the lane marking (18, 118) based on the image (16, 116), the vehicle offset being a measure of a distance from the left-side and the right-side of the host vehicle to the lane-marking; III) determining, based further on the image (16, 116), an object offset (44, 144) between the object (22, 122) and the lane marking (18, 118); IV) determining occurrences of lane departures (38, 138) by the vehicle (12, 112) when the vehicle offset (36, 136) is less than a deviation threshold (40, 140), V) incrementing a count (42, 142) for each of the occurrences of lane departures (38, 138); VI) refraining from incrementing the count (42, 142) in response to determining that the object offset (44, 144) is less than an offset threshold (46, 146) and a greater clearance between the vehicle (12, 112) and the object (22, 122) is provided by the lane departure (38, 138); and responsive to VII) determining that the count (42, 142) of the occurrences of lane departures (38, 138) exceeds a crossing threshold indicative of driver fatique, VIII) activating an alert device (28, 128) to alert an operator (30, 130) of the host vehicle (12, 112) of driver fatigue. I) capturing, by a camera (14, 114), an image (16, 116) including a lane marking (18, 118) on the left-side and on the right-side of the travel lane of a roadway (20, 120) of the host vehicle, and an object (22, 122) proximate to the vehicle (12, 112); II) determining, with a controller (32, 132) in communication with the camera (14, 114), a vehicle offset (36, 136) between the vehicle (12, 112) and the lane marking (18, 118) based on the image (16, 116), the vehicle offset being a measure of a distance from the left-side and the right-side of the host vehicle to the lane-marking; III) determining, based further on the image (16, 116), an object offset (44, 144) between the object (22, 122) and the lane marking (18, 118); IV) determining occurrences of lane departures (38, 138) by the vehicle (12, 112) when the vehicle offset (36, 136) is less than a deviation threshold (40, 140), V) incrementing a count (42, 142) for each of the occurrences of lane departures (38, 138); VI) refraining from incrementing the count (42, 142) in response to determining that the object offset (44, 144) is less than an offset threshold (46, 146) and a greater clearance between the vehicle (12, 112) and the object (22, 122) is provided by the lane departure (38, 138); and responsive to VII) determining that the count (42, 142) of the occurrences of lane departures (38, 138) exceeds a crossing threshold indicative of driver fatique, VIII) activating an alert device (28, 128) to alert an operator (30, 130) of the host vehicle (12, 112) of driver fatigue.
A process of preparing a copolyester which is used for the manufacture of containers that can withstand an ambient temperature of about 75 °C and which has an intrinsic viscosity greater than 0.50 dL/g measured as outlined in the description, the process comprising: - reacting terephthalic acid or ester thereof with monoethylene glycol and other diols, monomers, a nucleating agent, and a modified nanoclay at a temperature about 150 °C to 270 °C in the presence of catalysts under atmospheric pressure to obtain pre-polymers; - mixing polyethylene naphthalate and modified transparent polybutylene naphthalate having intrinsic viscosity >0.50 dL/g in the melt to obtain a uniform reaction mixture consisting of said pre-polymer; - polymerizing said reaction mixture at a temperature at about 270 °C and 295 °C under pressure below 1 millibar to obtain melt polymer of the required degree of polymerization; - extruding the melt polymer to obtain amorphous granules of intrinsic viscosity >0.40 dL/gm followed by crystallization thereof under atmospheric pressure and temperature at about 120 °C and 140 °C; and - solid state polymerizing the crystallized polymer to upgrade the intrinsic viscosity to above 0.50 dL/gm. - reacting terephthalic acid or ester thereof with monoethylene glycol and other diols, monomers, a nucleating agent, and a modified nanoclay at a temperature about 150 °C to 270 °C in the presence of catalysts under atmospheric pressure to obtain pre-polymers; - mixing polyethylene naphthalate and modified transparent polybutylene naphthalate having intrinsic viscosity >0.50 dL/g in the melt to obtain a uniform reaction mixture consisting of said pre-polymer; - polymerizing said reaction mixture at a temperature at about 270 °C and 295 °C under pressure below 1 millibar to obtain melt polymer of the required degree of polymerization; - extruding the melt polymer to obtain amorphous granules of intrinsic viscosity >0.40 dL/gm followed by crystallization thereof under atmospheric pressure and temperature at about 120 °C and 140 °C; and - solid state polymerizing the crystallized polymer to upgrade the intrinsic viscosity to above 0.50 dL/gm.
Microencapsulation process of inorganic phase change materials based on potassium nitrate in an inorganic nanostructured zinc oxide shell having a gravimetric ratio between ZnO shell and KNO3 encapsulated material of between 1:1 and 5:1, preferably 1:1 to 2:1, with applications for thermal energy storage at temperatures above 300 °C'; this process is characterized by the fact that the nanostructured zinc oxide shell is precipitated in-situ with potassium hydroxide on the potassium nitrate particles which are dispersed in the alcohol solution of zinc nitrate at 9.0 pH., followed by solvo-thermal treatment in an autoclave for 2 hours at 200 °C and 4.053 MPa (40 atm.) argon pressure, followed by spray-drying process of the suspensions at an air temperature of about 200 °C inside the spraying equipment to obtain grain sizes in the range of 25-50 μm.
A cutter assembly for an electric pencil sharpener, comprising: a cutter bracket having two sides; and a pencil sharpening hole defined in the cutter bracket for a pencil being inserted into the pencil sharpening hole; and a cutter mounted rotatably on the cutter bracket, having an engaging structure formed on at least one of the sides of the cutter bracket for engaging detachably a rotating frame in the electric pencil sharpener, wherein the cutter bracket further has atop, a front axle mount and a rear axle mount formed separately on the top of the cutter bracket; and a cutter space defiled between the axle mounts (422, 423), having an opened bottom and communicating with the pencil sharpening hole via the opened bottom; a cutter that is mounted rotatably in the cutter space and extends partially into the pencil sharpening hole via the opened bottom of the cutter space; and characterised in that the engaging structure comprises at least one rib formed on at least one of the sides of the cutter bracket between the front axle mount and the rear axle mount. a cutter bracket having two sides; and a pencil sharpening hole defined in the cutter bracket for a pencil being inserted into the pencil sharpening hole; and two sides; and a pencil sharpening hole defined in the cutter bracket for a pencil being inserted into the pencil sharpening hole; and a cutter mounted rotatably on the cutter bracket, having an engaging structure formed on at least one of the sides of the cutter bracket for engaging detachably a rotating frame in the electric pencil sharpener, wherein the cutter bracket further has atop, a front axle mount and a rear axle mount formed separately on the top of the cutter bracket; and a cutter space defiled between the axle mounts (422, 423), having an opened bottom and communicating with the pencil sharpening hole via the opened bottom; a cutter that is mounted rotatably in the cutter space and extends partially into the pencil sharpening hole via the opened bottom of the cutter space; and characterised in that the engaging structure comprises at least one rib formed on at least one of the sides of the cutter bracket between the front axle mount and the rear axle mount. atop, a front axle mount and a rear axle mount formed separately on the top of the cutter bracket; and a cutter space defiled between the axle mounts (422, 423), having an opened bottom and communicating with the pencil sharpening hole via the opened bottom; a cutter that is mounted rotatably in the cutter space and extends partially into the pencil sharpening hole via the opened bottom of the cutter space; and characterised in that the engaging structure comprises at least one rib formed on at least one of the sides of the cutter bracket between the front axle mount and the rear axle mount.
A User Equipment - UE - for a cellular network, the UE comprising a first interface for UE-to-Basestation communication configured to communicate with a base station of the cellular network, and a second interface for UE-to-UE communication configured to communicate with one or more other UEs (12A, 12B) of a UE-Group to which the UE belongs, wherein the UE is configured to receive via its first interface configuration data for configuring its second interface and to send control information to the one or more other UEs (12A, 12B) for informing them how to configure their respective second interface, and to coordinate, via the second interface, an intra-group communication between the one or more other UEs (12A, 12B) within the UE Group, and wherein the configuration data received from the base station contains physical resources for UE-to-UE communication between the UE and one or more of the other UEs (12A, 12B) of the UE-Group to which the UE belongs, and physical resources for the intra-group communication between two or more of the other UEs (12A, 12B) of the UE-Group to which the UE belongs wherein the UE may not be part of the intra-group communication. a first interface for UE-to-Basestation communication configured to communicate with a base station of the cellular network, and a second interface for UE-to-UE communication configured to communicate with one or more other UEs (12A, 12B) of a UE-Group to which the UE belongs, wherein the UE is configured to receive via its first interface configuration data for configuring its second interface and to send control information to the one or more other UEs (12A, 12B) for informing them how to configure their respective second interface, and to coordinate, via the second interface, an intra-group communication between the one or more other UEs (12A, 12B) within the UE Group, and wherein the configuration data received from the base station contains physical resources for UE-to-UE communication between the UE and one or more of the other UEs (12A, 12B) of the UE-Group to which the UE belongs, and physical resources for the intra-group communication between two or more of the other UEs (12A, 12B) of the UE-Group to which the UE belongs wherein the UE may not be part of the intra-group communication.
Process for manufacturing a glycerol-tricarboxylic acid polyester foam which comprises the steps of combining glycerol and a tri-carboxylic acid to provide a liquid reaction mixture and contacting the reaction mixture with a substrate under polymerization conditions, wherein the substrate has a top layer comprising one or more of metal, metal oxide, and metal halide.
A terminal device for generating a pilot signal, comprising a processing unit, wherein the processing unit is configured to: • obtain a correlation identifier and a port number (S 201); • when a value of the correlation identifier is equal to a preset value, determine a pilot sequence (S 202) based on: ∘ a timeslot number, and ∘ at least one parameter of: ▪ an identifier of a cell to which the terminal device belongs, ▪ an identifier of the terminal device, and ▪ a scramble identifier; • when the value of the correlation identifier is not equal to the preset value, determine the pilot sequence (S 202) based on: ∘ the correlation identifier and ∘ at least one parameter of: ▪ the identifier of the cell to which the terminal device belongs, ▪ the identifier of the terminal device, and ▪ the scramble identifier, wherein the timeslot number is not a parameter for generating the pilot sequence when the value of the correlation identifier is not equal to the preset value; • generate the pilot signal based on the pilot sequence and the port number (S 203); • send the pilot signal to a network device. • obtain a correlation identifier and a port number (S 201); • when a value of the correlation identifier is equal to a preset value, determine a pilot sequence (S 202) based on: ∘ a timeslot number, and ∘ at least one parameter of: ▪ an identifier of a cell to which the terminal device belongs, ▪ an identifier of the terminal device, and ▪ a scramble identifier; ∘ a timeslot number, and ∘ at least one parameter of: ▪ an identifier of a cell to which the terminal device belongs, ▪ an identifier of the terminal device, and ▪ a scramble identifier; ▪ an identifier of a cell to which the terminal device belongs, ▪ an identifier of the terminal device, and ▪ a scramble identifier; • when the value of the correlation identifier is not equal to the preset value, determine the pilot sequence (S 202) based on: ∘ the correlation identifier and ∘ at least one parameter of: ▪ the identifier of the cell to which the terminal device belongs, ▪ the identifier of the terminal device, and ▪ the scramble identifier, ∘ the correlation identifier and ∘ at least one parameter of: ▪ the identifier of the cell to which the terminal device belongs, ▪ the identifier of the terminal device, and ▪ the scramble identifier, ▪ the identifier of the cell to which the terminal device belongs, ▪ the identifier of the terminal device, and ▪ the scramble identifier, • generate the pilot signal based on the pilot sequence and the port number (S 203); • send the pilot signal to a network device.
A method for the prognosis of oral immunotherapy against proteins in cow's milk in a human subject unable to tolerate cow's milk, comprising determining the presence or absence of IgE antibodies in an isolated biological sample from the subject taken before starting OIT treatment (time 0), such as blood, serum, plasma, cerebrospinal fluid, peritoneal fluid, faces or urine, capable of recognizing peptides identified with any of the following sequences: a. At least one sequence selected from the group consisting of sequences SEQ ID NO: 18-32; and/or b. At least one sequence selected from the group consisting of sequences SEQ ID NO: 33-45; and/or c. At least one sequence selected from the group consisting of sequences SEQ ID NO: 46-63; and/or d. At least one sequence selected from the group consisting of sequences SEQ ID NO: 64-69; and/or e. At least one sequence selected from the group consisting of sequences SEQ ID NO: 70-75; wherein the prognosis of oral immunotherapy against proteins in cow's milk is established by correlating the number of peptide sequences recognized by IgE antibodies in the sample from the subject before starting OIT treatment (time 0) with reference values established based on those same peptide sequences which correlate the number of peptides recognized by IgE antibodies in the samples from the patients with the response after OIT treatment. a. At least one sequence selected from the group consisting of sequences SEQ ID NO: 18-32; and/or b. At least one sequence selected from the group consisting of sequences SEQ ID NO: 33-45; and/or c. At least one sequence selected from the group consisting of sequences SEQ ID NO: 46-63; and/or d. At least one sequence selected from the group consisting of sequences SEQ ID NO: 64-69; and/or e. At least one sequence selected from the group consisting of sequences SEQ ID NO: 70-75;